In contrast, ruxolitinib had a dramatic suppressing effect on STAT1, P-STAT1, and MX1 upregulation when it was added also pre-infection, also resulting in a dramatic increase in VSV protein accumulation, ultimately partially reversing the phenotype of siMETTL3-transfected SUIT-2 (Fig. 5D and E). Here, STAT1 is linked to infection.